Estrogen Intake and Copper Depositions: Implications for Alzheimer's Disease?

被引:21
作者
Amtage, Florian [1 ]
Birnbaum, Dzelila [4 ]
Reinhard, Thomas [4 ]
Niesen, Wolf-Dirk [1 ]
Weiller, Cornelius [1 ]
Mader, Irina [2 ]
Meyer, Philipp T. [3 ]
Rijntjes, Michel [1 ]
机构
[1] Univ Med Ctr Freiburg, Dept Neurol, Breisacherstr 64, DE-79106 Freiburg, Germany
[2] Univ Med Ctr Freiburg, Dept Neuroradiol, Freiburg, Germany
[3] Univ Med Ctr Freiburg, Dept Nucl Med, Freiburg, Germany
[4] Univ Eye Hosp Freiburg, Freiburg, Germany
关键词
C-11] PIB PET; Alzheimer's disease; Ceruloplasmin; Copper; Estrogen;
D O I
10.1159/000363688
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We present a patient with chronic postmenopausal estrogen intake with presence of Kayser-Fleischer ring in the cornea and Alzheimer's disease and discuss the pathophysiological mechanisms of estrogen intake and copper accumulation in various tissues, including the central nervous system. Sonography was compatible with copper accumulation in the basal ganglia, but the patient showed no clinical signs of Wilson's disease. Magnetic resonance imaging and positron emission tomography revealed a typical pattern for Alzheimer's disease. We propose increased copper levels as a direct effect of estrogen intake due to an augmented ATP7A-mRNA in the intestine. Moreover, we discuss the impact of elevated free serum copper on accompanying Alzheimer's disease, knowing that copper plays a crucial role in the formation of amyloid plaques and tau aggregation. This might offer a partial explanation for the observation that postmenopausal estrogen therapy is associated with a higher risk of mild cognitive impairment and Alzheimer's disease. (C) 2014 S. Karger AG, Basel
引用
收藏
页码:181 / 187
页数:7
相关论文
共 17 条
[1]
Corneal copper deposition associated with chronic lymphocytic leukemia [J].
Aldave, Anthony J. ;
King, Julie A. ;
Kim, Brian T. ;
Hopp, Lawrence .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2006, 142 (01) :174-176
[2]
Bucossi Serena, 2011, Int J Alzheimers Dis, V2011, P973692, DOI 10.4061/2011/973692
[3]
Copper in Alzheimer's Disease: A Meta-Analysis of Serum, Plasma, and Cerebrospinal Fluid Studies [J].
Bucossi, Serena ;
Ventriglia, Mariacarla ;
Panetta, Valentina ;
Salustri, Carlo ;
Pasqualetti, Patrizio ;
Mariani, Stefania ;
Siotto, Mariacristina ;
Rossini, Paolo Maria ;
Squitti, Rosanna .
JOURNAL OF ALZHEIMERS DISEASE, 2011, 24 (01) :175-185
[4]
RAISED SERUM COPPER AND CAERULOPLASMIN LEVELS IN SUBJECTS TAKING ORAL CONTRACEPTIVES [J].
CARRUTHE.ME ;
HOBBS, CB ;
WARREN, RL .
JOURNAL OF CLINICAL PATHOLOGY, 1966, 19 (05) :498-&
[5]
Garmizo G, 2008, OPTOMETRY VISION SCI, V85, P802
[6]
Hormonal regulation of the Menkes and Wilson copper-transporting ATPases in human placental Jeg-3 cells [J].
Hardman, Belinda ;
Michalczyk, Agnes ;
Greenough, Mark ;
Camakaris, James ;
Mercer, Julian F. B. ;
Ackland, M. Leigh .
BIOCHEMICAL JOURNAL, 2007, 402 :241-250
[7]
Assessment of copper status in pregnancy by means of determining the specific oxidase activity of ceruloplasmin [J].
Louro, MO ;
Cocho, JA ;
Tutor, JC .
CLINICA CHIMICA ACTA, 2001, 312 (1-2) :123-127
[8]
Binding of copper (II) ion to an Alzheimer's tau peptide as revealed by MALDI-TOF MS, CD, and NMR [J].
Ma, OF ;
Li, YM ;
Du, JT ;
Kanazawa, K ;
Nemoto, T ;
Nakanishi, H ;
Zhao, YF .
BIOPOLYMERS, 2005, 79 (02) :74-85
[9]
Neurological manifestations in Wilson's disease:: Report of 119 cases [J].
Machado, Alexandre ;
Chien, Hsin Fen ;
Deguti, Marta Mitiko ;
Cancado, Eduardo ;
Azevedo, Raymundo Soares ;
Scaff, Milberto ;
Barbosa, Egberto Reis .
MOVEMENT DISORDERS, 2006, 21 (12) :2192-2196
[10]
SERUM COPPER ALTERATION AFTER INGESTION OF AN ORAL CONTRACEPTIVE [J].
OLEARY, JA ;
SPELLACY, WN .
SCIENCE, 1968, 162 (3854) :682-&